FACT Quality Immune Effector Cellular Therapy for the Treatment of Solid Tumors: General Concepts and Need for Harmonization of Standards
Wednesday, September 28, 2022 (11am - 12:30pm US/Eastern)
This webinar offers an introduction to Immune Effector Cellular (IEC) Therapy for the treatment of solid tumors. Basem William, MD, MRCP, FACP from the OhioHealth Blood and Marrow Transplant and Cellular Therapy Program and Sarah Nikiforow, MD, PhD from the Dana-Farber Cancer Institute Cell Manipulation Core Facility in Boston will discuss unique challenges and considerations in IEC manufacturing; list subtypes of IECs in solid tumors including TILs, CAR-T cells, and TCRs, and examine the need for quality standards.
Registration Fees:These fees are available through 09/28/2022
|Webinar Registrants||$100.00||Webinar Registrants|
|Inspectors||$0.00||Inspector & Inspector Trainees|